BMO Capital analyst Jeffrey Silber raised his price target on Adtalem Global Education to $55 and kept his Outperform rating after its adjusted Q4 earnings of 97c topped consensus by 1c. The analyst notes that the company's enrollment trends at Chamberlain campuses were "solid", even though they continued to decline in the "RN to BSN programs". Silber also states that the "somewhat mixed" segment trends were partially offset by cost management. The analyst warns that the stock may give back some of its recent gains but expects the company's focus on "Medical/Healthcare and Financial Services" to help it outperform the broader industry.